Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Former PhRMA CEO Tauzin joins CaptureRx

This article was originally published in Scrip

Executive Summary

Billy Tauzin, a former congressman and PhRMA CEO, has joined the board of CaptureRx, a pharmaceutical benefits management company, also serving as chief industry relations officer. He has a personal interest in the company's 340B federal drug programme, which lowers the cost of healthcare at no cost to the government, having been diagnosed with a rare intestinal cancer in 2004 and beating his 1% chance of survival thanks to innovative drug therapies. As CEO of PhRMA, Mr Tauzin helped create the Partnership for Prescription Assistance, which provides free medicines to Americans.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

SC014144

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel